Insider · CIK 0001796465
Giguere Lee
Reports to the SEC for 2 companies · SAINT-LAURENT, A8
Transactions
8
Companies
2
Filings
6
CIK
0001796465
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-30 | ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-01-29 | ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-03-15 | ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-08-05 | CHIASMA, INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-08-05 | CHIASMA, INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-08-05 | CHIASMA, INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-02-09 | CHIASMA, INCStock Option (Right to Buy)A Award | — |
| 2020-02-14 | CHIASMA, INCStock Option (Right to Buy)A Award | — |
Recent filings
- 4Giguere Lee0000929638-26-000483SEC(opens sec.gov)
- 4Giguere Lee0000929638-25-000479SEC(opens sec.gov)
- 4Giguere Lee0000929638-24-001049SEC(opens sec.gov)
- 4Giguere Lee0001209191-21-050023SEC(opens sec.gov)
- 4Giguere Lee0001209191-21-009810SEC(opens sec.gov)
- 4Giguere Lee0001209191-20-010042SEC(opens sec.gov)
Companies
Address
C/O 4868 RUE LEVY, SUITE 220
SAINT-LAURENT, A8, H4R 2P1